Skip to main content
SpringerLink
Log in

OTC Medication and Pharmaceutical Care

  • Chapter
  • First Online:
The Pharmacist Guide to Implementing Pharmaceutical Care

  • 2042 Accesses

Abstract

With the increasing availability and use of over-the-counter (OTC) or nonprescription medicines by consumers globally, pharmacists have an integral role in delivering pharmaceutical care to support safe and appropriate OTC medication use. This chapter provides an overview of OTC medication use within the context of primary care and self-care. It outlines the role of pharmacists in relation to OTC medicines, details the medication-centered and service-oriented systems for delivering pharmaceutical care relevant to consumer OTC medication use, and discusses current and future scopes of practice within the context of OTC medication and pharmaceutical care .

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pharmaceutical Care Network Europe. Position paper on the definition of pharmaceutical care 2013 [Internet]. 2013. Available from: http://www.pcne.org//upload/files/3_PCNE_Definition_Position_Paper_final.pdf. Cited 9 Sept 2017.

  2. World Health Organization. Declaration of Alma-Ata [Internet]. n.d. Available from: http://www.euro.who.int/__data/assets/pdf_file/0009/113877/E93944.pdf. Cited 9 Sept 2017.

  3. World Health Organization Regional Office for Europe. Main terminology [Internet]. 2017. Available from: http://www.euro.who.int/en/health-topics/Health-systems/primary-health-care/main-terminology. Cited 9 Sept 2017.

  4. Ostermann H, Renner A-T, Bobek J, Schneider P, Vogler S. A cost-benefit analysis of self-care systems in the European Union: final report [Internet]. European Commission. 2015. Available from: https://ec.europa.eu/health/sites/health/files/patient_safety/docs/2015_selfcaresystemsstudy_en.pdf. Cited 19 Oct 2017.

  5. International Pharmaceutical Federation. Pharmacy as a gateway to care: helping people towards better health [Internet]. The Hague, The Netherlands: International Pharmaceutical Federation. 2017. Available from: http://www.fip.org/files/fip/publications/2017-04-Pharmacy-Gateway-Care.pdf. Cited 19 Oct 2017.

  6. Consumer Healthcare Products Association. Statistics on OTC use. [Internet] 2017; Available from: http://www.chpa.org/marketstats.aspx. Cited 19 Nov 2017.

  7. Kaae S, Traulsen JM, Nørgaard LS. Customer interest in and experience with various types of pharmacy counselling—a qualitative study. Health Expect. 2014;17(6):852–62.

    Article  Google Scholar 

  8. World Self-Medication Industry. Switch: prescription to nonprescription medicines switch [Internet]. France: World Self-Medication Industry. 2009. Available from: http://www.wsmi.org/wp-content/data/pdf/wsmi_switchbrochure.pdf. Cited 19 Oct 2017.

  9. Schneider H, Roehrig RC, Coppolecchia R, Ming D, Garwin J, Qi D, et al. White paper on the benefits of OTC medicines in the United States: report of the Consumer Healthcare Products Association’s Clinical/Medical Committee. Pharm Today. 2010;16(10):68–79.

    Google Scholar 

  10. Pharmaceutical Society of Australia. Professional Practice Standards—Version 5—2017 [Internet]. Canberra, ACT: Pharmaceutical Society of Australia. 2017. Available from: http://www.psa.org.au/wp-content/uploads/Professional-Practice-Standards-V5-PDF-5.5mb.pdf. Cited 19 Oct 2017.

  11. Blenkinsopp A, Paxton P, Blenkinsopp J. Symptoms in the pharmacy: a guide to the management of common illnesses. 7th ed. Somerset, NJ: Wiley; 2013. p. 9–13.

    Google Scholar 

  12. The Pharmacy Guild of Australia, Pharmaceutical Society of Australia. What-Stop-Go protocol for providing Pharmacy medicines and Pharmacist Only medicines; CARER protocol for providing Pharmacy medicines and Pharmacist Only medicines [Internet]. The Pharmacy Guild of Australia, Pharmaceutical Society of Australia. n.d. Available from: http://pharm-assist.com.au/wp-content/uploads/2017/04/whatstopsprotocols.pdf. Cited 19 Oct 2017.

  13. Tong V, Raynor DK, Hamrosi KK, Acharya B, Panchal N, Aslani P. Consumer opinions on existing and proposed Australian over-the-counter medicine labeling strategies in comparison with the standardized US Drug Facts label. Ther Innov Regul Sci. 2016;50(4):427–35.

    Article  Google Scholar 

  14. Tong V, Raynor DK, Aslani P. Comparative user testing of Australian and UK over-the-counter labels and leaflets for diclofenac. Ther Innov Regul Sci. https://doi.org/10.1177/2168479017711730. Published online 8 Jun 2017.

    Article  Google Scholar 

  15. International Pharmaceutical Federation. Pharmacy at a glance—2015–2017 [Internet]. The Hague, The Netherlands: International Pharmaceutical Federation. 2017. Available at: https://fip.org/files/fip/publications/2017-09-Pharmacy_at_a_Glance-2015-2017.pdf. Cited 21 Sept 2017.

  16. Gauld NJ, Kelly FS, Kurosawa N, Bryant LJM, Emmerton LM, Buetow SA. Widening consumer access to medicines through switching medicines to non-prescription: a six country comparison. PLoS ONE. 2014;9(9):e107726.

    Article  Google Scholar 

  17. Pharmaceutical Society of Australia. Pharmacist Only medicine (S3) guidelines [Internet]. 2017. Available from: http://www.psa.org.au/practice-support-and-tools/guidelines-and-tools/pharmacist-only-medicine-s3-guidelines. Cited 20 Nov 2017.

  18. Pharmacy Council of New Zealand. Protocol for the sale and supply of Pharmacist Only medicines for chronic conditions [Internet]. Pharmacy Council of New Zealand. 2011. Available from: http://www.pharmacycouncil.org.nz/Portals/12/Documents/standardsguidelines/POMCC%20Protocol%20web.pdf?ver=2017-02-20-104825-763. Updated Mar 2011; Cited 10 Oct 2017.

  19. Ung COL, Harnett J, Hu H. Community pharmacist’s responsibilities with regards to traditional medicine/complementary medicine products: a systematic literature review. Res Social Adm Pharm. 2017;13(4):686–716.

    Article  Google Scholar 

  20. Pharmacy Council of New Zealand. Complementary and alternative medicines—best practice guidance for pharmacists [Internet]. Pharmacy Council of New Zealand. 2012. Available from: http://www.pharmacycouncil.org.nz/Portals/12/Documents/standardsguidelines/PCNZ%20StatementAltMeds.pdf?ver=2017-02-20-104316-143. Cited 10 Oct 2017.

  21. Simoens S, Lobeau M, Verbeke K, van Aerschot A. Patient experiences of over-the-counter medicine purchases in Flemish community pharmacies. Pharm World Sci. 2009;31(4):450–7.

    Article  Google Scholar 

  22. Sleath B, Rubin RH, Campbell W, Gwyther L, Clark T. Physician–patient communication about over-the-counter medications. Soc Sci Med. 2001;53(3):357–69.

    Article  CAS  Google Scholar 

  23. Westerlund LOT, Marklund BRG, Handl WHA, Thunberg ME, Allebeck P. Nonprescription drug-related problems and pharmacy interventions. Ann Pharmacother. 2001;35(11):1343–9.

    Article  CAS  Google Scholar 

  24. Eickhoff C, Hämmerlein A, Griese N, Schulz M. Nature and frequency of drug-related problems in self-medication (over-the-counter drugs) in daily community pharmacy practice in Germany. Pharmacoepidemiol Drug Saf. 2012;21(3):254–60.

    Article  Google Scholar 

  25. van Eikenhorst L, Salema N-E, Anderson C. A systematic review in select countries of the role of the pharmacist in consultations and sales of non-prescription medicines in community pharmacy. Res Social Adm Pharm. 2017;13(1):17–38.

    Article  Google Scholar 

  26. Williams KA, Emmerton LM, Taylor R, Werner J, Benrimoj SI. Non-prescription medicines and Australian community pharmacy interventions: rates and clinical significance. Int J Pharm Pract. 2011;19(3):156–65.

    Article  Google Scholar 

  27. Chan P, Grindrod KA, Bougher D, Pasutto FM, Wilgosh C, Eberhart G, et al. A systematic review of remuneration systems for clinical pharmacy care services. Can Pharm J (Ott). 2008;141(2):102–12.

    Article  Google Scholar 

  28. Houle SKD, Grindrod KA, Chatterley T, Tsuyuki RT. Paying pharmacists for patient care: a systematic review of remunerated pharmacy clinical care services. Can Pharm J (Ott). 2014;147(4):209–32.

    Article  Google Scholar 

  29. Paudyal V, Watson MC, Sach T, Porteous T, Bond CM, Wright DJ, et al. Are pharmacy-based minor ailment schemes a substitute for other service providers? A systematic review. Br J Gen Pract. 2013;63(612):e472–81.

    Article  Google Scholar 

  30. Baqir W, Learoyd T, Sim A, Todd A. Cost analysis of a community pharmacy ‘minor ailment scheme’ across three primary care trusts in the North East of England. J Public Health (Oxf). 2011;33(4):551–5.

    Article  CAS  Google Scholar 

  31. Erni P, von Overbeck J, Reich O, Ruggli M. netCare, a new collaborative primary health care service based in Swiss community pharmacies. Res Social Adm Pharm. 2016;12(4):622–6.

    Article  Google Scholar 

  32. International Pharmaceutical Federation. FIP Statement of Policy–Pharmacy: gateway to care [Internet]. The Hague, The Netherlands: International Pharmaceutical Federation. 2017. Available from: http://fip.org/www/uploads/database_file.php?id=384&table_id=. Cited 10 Oct 2017.

  33. Rutter P. Role of community pharmacists in patients’ self-care and self-medication. Integr Pharm Res Pract. 2015;4:57–65.

    Article  Google Scholar 

  34. Wazaify M, Shields E, Hughes CM, McElnay JC. Societal perspectives on over-the-counter (OTC) medicines. Fam Pract. 2005;22(2):170–6.

    Article  Google Scholar 

  35. Xu T, de Almeida Neto AC, Moles RJ. A systematic review of simulated-patient methods used in community pharmacy to assess the provision of non-prescription medicines. Int J Pharm Pract. 2012;20(5):307–19.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The University of Sydney, Camperdown, Australia

    Vivien Tong & Parisa Aslani

Authors
  1. Vivien Tong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Parisa Aslani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Parisa Aslani .

Editor information

Editors and Affiliations

  1. Instituto Universitário Egas Moniz (IUEM), Monte da Caparica, Portugal

    Filipa Alves da Costa

  2. van Mil Consultancy, Zuidlaren, The Netherlands

    J. W. Foppe van Mil

  3. Universidad de San Martín de Porres, Lima, Peru

    Aldo Alvarez-Risco

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tong, V., Aslani, P. (2019). OTC Medication and Pharmaceutical Care. In: Alves da Costa, F., van Mil, J., Alvarez-Risco, A. (eds) The Pharmacist Guide to Implementing Pharmaceutical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-92576-9_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-92576-9_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-92575-2

  • Online ISBN: 978-3-319-92576-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation